 |
|
Middle Segment Pancreatectomy
A Novel Technique for Conserving Pancreatic Tissue
Andrew L. Warshaw, MD;
David W. Rattner, MD;
Carlos Fernández-del Castillo, MD;
Kaspar Z'graggen, MD
Arch Surg. 1998;133:327-331.
Pancreatoduodenectomy and extended distal pancreatectomy for benign tumors in the pancreatic neck and body incur a notable waste of normal tissue and unnecessary risk of both diabetes mellitus and splenic loss. We describe the technique of a limited resection of the middle portion of the pancreas, termed middle segment pancreatectomy, and report our results in 12 patients. Middle segment pancreatectomy was used in 12 consecutive patients with pancreatic tumors of the neck or body. The transected pancreatic head was sutured with duct ligation, and a Roux-en-Y loop of jejunum was anastomosed to the tail using mucosa-to-mucosa duct approximation and a 5F catheter for duct stenting and drainage. In 12 patients, 7 with cystic tumors (5 patients with serous cystadenoma; 2 patients with mucinous cystic neoplasms), 3 with islet cell adenomas, 1 with islet cell carcinoma, and 1 with intraductal papillary mucinous tumor, the tumor was resected by a middle segment pancreatectomy. In each case, the tumor, measuring 0.9 to 5.2 cm, lay in the neck or body of the pancreas and could not be safely enucleated without compromising the pancreatic duct. Each tumor was resected with clear margins. Two patients had a temporary pancreatic fistula; 1 patient had delayed gastric emptying. Median postoperative length of stay was 8 days. No patient became diabetic or required oral pancreatic enzyme supplements. No local recurrences occurred after a mean follow-up of 18 months. Middle segment pancreatectomy is a safe and effective technique for resecting selected pancreatic tumors in the neck and body of the pancreas while preserving pancreatic endocrine and exocrine function and the spleen.
From the Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston.
RELATED ARTICLE
Middle Segment Pancreatectomy—Invited Commentary
Keith D. Lillemoe
Arch Surg. 1998;133(3):331.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Comparison of Central and Extended Left Pancreatectomy for Lesions of the Pancreatic Neck
Ocuin et al.
Ann. Surg. Oncol. 2008;15:2096-2103.
ABSTRACT
| FULL TEXT
Central Pancreatectomy: Single-Center Experience of 50 Cases
Adham et al.
Arch Surg 2008;143:175-180.
ABSTRACT
| FULL TEXT
Evolving Patterns in the Detection and Outcomes of Pancreatic Neuroendocrine Neoplasms: The Massachusetts General Hospital Experience From 1977 to 2005
Vagefi et al.
Arch Surg 2007;142:347-354.
ABSTRACT
| FULL TEXT
Central pancreatectomy: a technique for the resection of pancreatic neck lesions.
Christein et al.
Arch Surg 2006;141:293-299.
ABSTRACT
| FULL TEXT
Human pancreatic exocrine response to nutrients in health and disease
Keller and Layer
Gut 2005;54:1-28.
FULL TEXT
Cystic Neoplasms of the Pancreas
Brugge et al.
NEJM 2004;351:1218-1226.
FULL TEXT
Changes in Morbidity After Pancreatic Resection: Toward the End of Completion Pancreatectomy
Buchler et al.
Arch Surg 2003;138:1310-1314.
ABSTRACT
| FULL TEXT
Ten-Year Experience With 733 Pancreatic Resections: Changing Indications, Older Patients, and Decreasing Length of Hospitalization
Balcom IV et al.
Arch Surg 2001;136:391-398.
ABSTRACT
| FULL TEXT
The Increasing Problem of Unusual Pancreatic Tumors
Sheehan et al.
Arch Surg 2000;135:644-650.
ABSTRACT
| FULL TEXT
|
